Stay updated with breaking news from Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens, co-founder and president of Quotient Therapeutics Inc., a company that emerged from stealth this week, backed by two years of platform development and a $50 million investment from Flagship Pioneering.
Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens, co-founder and president of Quotient Therapeutics Inc., a company that emerged from stealth this week, backed by two years of platform development and a $50 million investment from Flagship Pioneering.
Saskatoon, Oct. 26, 2023 (GLOBE NEWSWIRE) -- SASKATOON — World-class talent and sequencing technology at the Global Institute for Food Security (GIFS) at...
INTEGRA Biosciences is excited to announce the launch of MIRO CANVAS, a compact digital microfluidics platform for fully automated next generation sequencing (NGS) sample preparation. Click to read more...
Integra Biosciences introduces MIRO CANVAS, a compact digital microfluidics platform designed to fully automate next-generation sequencing (NGS) sample preparation. Click to read more...